Having a baby is a tremendous joy, but it also brings a host of new responsibilities including safeguarding your baby’s long-term health. One of the first steps you can take towards safeguarding your child’s health is through newborn genetic screening. This simple test can detect any hidden health conditions that may not be apparent at birth but can have serious consequences for your child’s future development. Early detection opens the door for early treatment, helping to prevent life-altering outcomes such as developmental delay, physical handicap, or life-threatening disease in babies.
Along with genetic screening, parents in India are now opting for stem cell banking to be better prepared for their child’s future health needs. One of the popular stem cell banks in India is LifeCell, which offers service to bank your baby’s umbilical cord stem cells at birth for potential future use. While newborn screening helps with early detection of hidden health conditions, stem cell banking offers the possibility of future treatment options, providing parents with added confidence for their child’s long-term well-being.
What Is Newborn Genetic Screening?
Newborn genetic screening is a public health program where babies are tested at birth for certain genetic, metabolic, and congenital disorders. These conditions may not be immediately apparent but can lead to severe health complications later if left untreated. Some examples of the diseases detected through genetic testing include down syndrome, sickle cell anemia, cystic fibrosis.
The most common method of doing this screening is through a small blood test, typically collected from a small prick on the baby’s heel. This blood is then tested in a laboratory to check for a range of disorders. If you’d like to learn more about the genetic screening process, you can explore a detailed blog here.
Importance Of Newborn Genetic Screening
The primary purpose of newborn screening is to find serious health problems in babies as early as possible, often before any symptoms appear. Detecting these conditions early is crucial because it allows doctors to begin treatment right away, often preventing long-term health problems or even stopping the condition from causing any harm at all.
Many of the medical conditions detected through newborn screening, if left untreated, can cause serious issues like permanent damage to the nervous system. Thus, making it hard for the baby to learn or move normally. Others can cause physical, mental, or intellectual disabilities in children. And, in the most severe cases, these conditions, if not treated on time, can even be life-threatening to the baby.
By screening newborns early, we can intervene before these conditions have a chance to cause long-term damage. It gives babies the best possible chance to grow up healthy and reach their full potential.
Challenges In Newborn Genetic Screening In India
There are a number of challenges involved in initiating newborn screening programs in India. One of the major challenges is low awareness. Many individuals do not realize the significance of newborn screening in detecting serious medical conditions early on. Additionally, limited healthcare spending, absence of a definitive government policy, and lack of political support further slow down efforts to implement widespread screening initiatives in India. Historically, Indian health policies were primarily aimed at decreasing disease deaths from infectious diseases and did not focus on addressing disabilities caused by genetic conditions. Other factors, such as inadequate health education, premature discharge of newborns from hospitals, and a large proportion of births occurring outside of hospital settings, also contribute to the lack of a comprehensive newborn screening system.
Another issue is the lack of sufficient quality data on the prevalence of genetic diseases across the country, making it difficult to plan and design an effective national program. But some states, such as Kerala, Goa, and Chandigarh, have already begun newborn screening programs, demonstrating that state-level programs are feasible and can serve as models for wider implementation.
In fact, recognizing the importance of early detection, the Indian Council of Medical Research (ICMR) in 2018 suggested newborn screening for diseases such as congenital hypothyroidism (CH) and congenital adrenal hyperplasia (CAH). These diseases are significant to screen for because CH is a major cause of preventable intellectual disability, and CAH may lead to severe health issues or even death if left untreated. Additionally, The Indian Society for Pediatric and Adolescent Endocrinology has also issued guidelines regarding screening, diagnosis, and treatment of CH.
Therefore, in a country like India, with its regional diversity and varying health profiles, it is necessary to first understand local disease patterns and then design a more effective, targeted national screening strategy.
In Conclusion
Finally, newborn genetic screening is an essential process for detecting serious health conditions in babies at an early stage. Detection of genetic diseases early can prevent serious complications and enhance the quality of the child’s life. While India is still working on initiating a nationwide genetic screening program, the progress made by some states offers hope for broader adoption in the near future.
In addition to genetic screening, stem cell banking provides a second avenue for parents to safeguard their baby’s future health. Services such as LifeCell’s community stem cell banking program, which preserves baby’s umbilical cord stem cells at birth, offers parents the chance to safeguard their baby & entire family against potential future health challenges. Together, newborn genetic screening and stem cell banking create a comprehensive approach to protecting the future well-being of India’s next generation.